Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FFF4T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,571
Award facts
- Contract value 100% obligated
- $35,571.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,571.00 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packaging) on October 22, 2025, with completion scheduled for October 23, 2025. This firm fixed price delivery order is unclassified as a set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other autoimmune conditions, representing a specialty pharmaceutical product within the Defense Health Agency's medical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. As the prime contractor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. The company's selection through open competition reflects its capability to fulfill federal medical procurement requirements, and this delivery order exemplifies the routine pharmaceutical fulfillment activities conducted under the larger IDC framework supporting Defense Health Agency operations.
Quick answers
Who was awarded contract SPE2DR26FFF4T?
SPE2DR26FFF4T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FFF4T worth?
The government has obligated $35,571 on SPE2DR26FFF4T.
Is contract SPE2DR26FFF4T an order under another contract?
Yes. SPE2DR26FFF4T is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFF4T competed?
The extent of competition for SPE2DR26FFF4T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award